Rep. Jefferson Shreve Sells Albemarle Corporation (NYSE:ALB) Shares

Representative Jefferson Shreve (R-Indiana) recently sold shares of Albemarle Corporation NYSE: ALB. In a filing disclosed on June 22nd, the Representative disclosed that they had sold between $15,001 and $50,000 in Albemarle stock on May 12th. The trade occurred in the Representative's "CRT - STANDARD UNIT TRUST" account.

Representative Jefferson Shreve also recently made the following trade(s):

• Sold $15,001 - $50,000 in shares of Hubbell NYSE: HUBB on 5/12/2025.
• Sold $50,001 - $100,000 in shares of Trane Technologies NYSE: TT on 5/12/2025.
• Sold $15,001 - $50,000 in shares of RTX NYSE: RTX on 5/12/2025.
• Sold $50,001 - $100,000 in shares of NiSource NYSE: NI on 5/12/2025.
• Sold $50,001 - $100,000 in shares of Johnson & Johnson NYSE: JNJ on 5/12/2025.
• Sold $15,001 - $50,000 in shares of AppLovin NASDAQ: APP on 5/12/2025.
• Sold $15,001 - $50,000 in shares of Fiserv NYSE: FI on 5/12/2025.
• Sold $15,001 - $50,000 in shares of CNO Financial Group NYSE: CNO on 5/12/2025.
• Sold $50,001 - $100,000 in shares of Cboe Global Markets NASDAQ: CBOE on 5/12/2025.
• Sold $15,001 - $50,000 in shares of Lam Research NASDAQ: LRCX on 5/12/2025.

Albemarle Stock Down 0.4%

NYSE:ALB traded down $0.34 on Friday, hitting $83.84. The stock had a trading volume of 5,377,902 shares, compared to its average volume of 4,448,243. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.26 and a current ratio of 2.11. The stock has a market cap of $9.87 billion, a P/E ratio of -7.54 and a beta of 1.63. Albemarle Corporation has a 1 year low of $49.43 and a 1 year high of $113.91. The firm's fifty day simple moving average is $64.81 and its two-hundred day simple moving average is $69.89.

Albemarle (NYSE:ALB - Get Free Report) last released its earnings results on Wednesday, April 30th. The specialty chemicals company reported ($0.18) earnings per share for the quarter, beating analysts' consensus estimates of ($0.62) by $0.44. Albemarle had a negative net margin of 22.39% and a negative return on equity of 1.92%. The firm had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.18 billion. During the same period in the prior year, the firm earned $0.26 EPS. The company's revenue was down 20.9% compared to the same quarter last year. Analysts predict that Albemarle Corporation will post -0.04 earnings per share for the current year.

Albemarle Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 1st. Shareholders of record on Friday, September 12th will be paid a $0.405 dividend. The ex-dividend date of this dividend is Friday, September 12th. This represents a $1.62 annualized dividend and a yield of 1.93%. Albemarle's dividend payout ratio (DPR) is -14.57%.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on ALB. Citigroup reduced their target price on shares of Albemarle from $85.00 to $64.00 and set a "neutral" rating for the company in a research report on Tuesday, April 15th. Mizuho set a $76.00 price objective on shares of Albemarle in a report on Tuesday, July 15th. KeyCorp cut their price objective on shares of Albemarle from $95.00 to $87.00 and set an "overweight" rating for the company in a report on Monday, July 14th. Robert W. Baird cut their price objective on shares of Albemarle from $77.00 to $60.00 and set a "neutral" rating for the company in a report on Tuesday, April 15th. Finally, Wells Fargo & Company raised their price target on shares of Albemarle from $60.00 to $75.00 and gave the company an "equal weight" rating in a report on Monday, July 14th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $91.00.

Hedge Funds Weigh In On Albemarle

Large investors have recently added to or reduced their stakes in the business. Assetmark Inc. increased its position in shares of Albemarle by 340.6% in the fourth quarter. Assetmark Inc. now owns 304 shares of the specialty chemicals company's stock valued at $26,000 after acquiring an additional 235 shares during the period. Pilgrim Partners Asia Pte Ltd purchased a new position in shares of Albemarle in the fourth quarter valued at about $34,000. Orion Capital Management LLC purchased a new position in shares of Albemarle in the fourth quarter valued at about $35,000. SJS Investment Consulting Inc. purchased a new position in shares of Albemarle in the first quarter valued at about $32,000. Finally, Centricity Wealth Management LLC purchased a new position in shares of Albemarle in the fourth quarter valued at about $39,000. Hedge funds and other institutional investors own 92.87% of the company's stock.

About Representative Shreve

Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana's 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana's 6th Congressional District. He declared candidacy for the 2026 election. Email editor@ballotpedia.org to notify us of updates to this biography. Jefferson Shreve earned a bachelor's degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve's career experience includes working as a real estate executive. Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.

Albemarle Company Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.